Cargando…

A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use

BACKGROUND: Castration-resistant prostate cancer (CRPC) is associated with high costs and healthcare resource utilization (HCRU). OBJECTIVE: This study followed patients with CRPC through their continuum of care and analyzed claims data regarding treatments, total HCRU, and costs, both before and af...

Descripción completa

Detalles Bibliográficos
Autores principales:	Appukkuttan, Sreevalsa, Tangirala, Krishna, Babajanyan, Svetlana, Wen, Lonnie, Simmons, Stacey, Shore, Neal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426332/ https://www.ncbi.nlm.nih.gov/pubmed/31641995 http://dx.doi.org/10.1007/s41669-019-00185-8

Ejemplares similares

Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
por: Huntington, Scott F., et al.
Publicado: (2022)

Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer
por: Appukkuttan, Sreevalsa, et al.
Publicado: (2021)

Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center
por: McKay, Rana R., et al.
Publicado: (2020)

Physician preferences for non-metastatic castration-resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

Clinical outcomes, management, and treatment patterns in patients with metastatic castration‐resistant prostate cancer treated with radium‐223 in community compared to academic settings
por: Sartor, Oliver, et al.
Publicado: (2021)

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

Real-world burden of adverse events for apalutamide- or enzalutamide-treated non-metastatic castration-resistant prostate cancer patients in the United States
por: Hussain, Arif, et al.
Publicado: (2022)

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
por: Kocaata, Zeki, et al.
Publicado: (2022)

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2021)

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer
por: Shore, Neal, et al.
Publicado: (2020)

Age-structured SIR model and resource growth dynamics: a COVID-19 study
por: Babajanyan, S. G., et al.
Publicado: (2021)

Comparing costs and health care resource utilization between nmHSPC and mHSPC patients: a retrospective claims analysis
por: Ko, Gilbert Chao, et al.
Publicado: (2022)

Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
por: Saad, Fred, et al.
Publicado: (2021)

Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
por: Schultz, Neil M., et al.
Publicado: (2018)

Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis
por: Mehta, Rajesh R., et al.
Publicado: (2020)

Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis
por: Toro, Walter, et al.
Publicado: (2023)

Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims Study
por: Shah, Nirmish, et al.
Publicado: (2020)

Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany
por: Christensen, Stefan, et al.
Publicado: (2019)

Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis
por: Borchmann, Peter, et al.
Publicado: (2022)

Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis
por: Quignot, Nadia, et al.
Publicado: (2023)

Health Care Resource Utilization Following Initiation of a Triptan: A Retrospective Claims Analysis
por: Messali, Andrew, et al.
Publicado: (2014)

Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis
por: Jackson, Robert, et al.
Publicado: (2015)

Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia
por: Shore, Neal
Publicado: (2015)

All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis
por: Flórez-Tanus, Álvaro, et al.
Publicado: (2018)

Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database
por: Eichenfield, Lawrence F., et al.
Publicado: (2020)

Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
por: Gauthier, Geneviève, et al.
Publicado: (2017)

Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
por: Bell, Christopher F, et al.
Publicado: (2020)

Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data
por: Stephan, Anna-Janina, et al.
Publicado: (2022)

Treatment patterns, healthcare resource utilization, and costs in patients with moderate‐to‐severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study
por: Tada, Yayoi, et al.
Publicado: (2022)

Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis
por: Nelson, Winnie W, et al.
Publicado: (2021)

Administrative Claims Analysis of All-Cause Annual Costs of Care and Resource Utilization by Age Category for Ulcerative Colitis Patients
por: Bickston, Stephen J., et al.
Publicado: (2008)

Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims
por: Haidar, Samer, et al.
Publicado: (2023)

Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy–a claims data analysis
por: Brandes, Alina, et al.
Publicado: (2016)

Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims
por: Freedland, Stephen J., et al.
Publicado: (2023)

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
por: Schroeder, Krista M, et al.
Publicado: (2019)

Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims
por: Sacks, Naomi C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4fp609j2s0hvqq34lqjas63ist